Johnson & Johnson and BARDA are committed to investing over $ 1 billion together in research and development of the new coronavirus vaccine; The company expects to initiate phase 1 clinical trials for the candidate vaccine no later than September 2020.
For more information, please see the Romanian version of the article, here.
